What Is 2-Hydroxyglutaric aciduria

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 2-Hydroxyglutaric aciduria is a rare inherited metabolic disorder characterized by elevated levels of 2-hydroxyglutaric acid in urine and body fluids, leading to severe neurological symptoms. It is caused by mutations in the L2HGDH gene and typically manifests in infancy, with most cases diagnosed before age 2.

Key Facts

2-Hydroxyglutaric aciduria affects fewer than 1 in 1,000,000 individuals worldwide.
Over 80% of cases are linked to mutations in the L2HGDH gene.
Symptoms usually appear before age 2, often within the first year of life.
Diagnosis is confirmed via urine organic acid analysis showing elevated 2-hydroxyglutaric acid.
The disorder is inherited in an autosomal recessive pattern.

Overview

2-Hydroxyglutaric aciduria is a rare neurometabolic disorder that disrupts normal brain development and function due to the accumulation of 2-hydroxyglutaric acid. It primarily affects the central nervous system and is most commonly diagnosed in early childhood, often leading to developmental delays and seizures.

The condition is classified as an organic aciduria, a group of disorders involving abnormal organic acid metabolism. While extremely rare, it has been documented in multiple ethnic populations, with higher prevalence in regions with increased consanguinity. Early diagnosis through metabolic screening is crucial for managing symptoms.

Incidence: Affects fewer than 1 in 1,000,000 individuals globally, making it one of the rarest metabolic disorders.
Genetic cause: Mutations in the L2HGDH gene on chromosome 14q22.1 disrupt the breakdown of L-2-hydroxyglutarate, leading to toxic accumulation.
Onset: Symptoms typically emerge before age 2, with some cases detected in infancy through newborn screening or clinical evaluation.
Diagnosis: Confirmed by detecting elevated 2-hydroxyglutaric acid in urine using gas chromatography-mass spectrometry (GC-MS).
Inheritance: Follows an autosomal recessive pattern, meaning both parents must carry a mutated gene for a child to be affected.

How It Works

Understanding 2-hydroxyglutaric aciduria requires examining the biochemical and genetic mechanisms behind its progression. The disorder stems from impaired enzyme function, leading to toxic metabolite buildup in the brain and other tissues.

L-2-Hydroxyglutarate dehydrogenase: This mitochondrial enzyme, encoded by L2HGDH, normally converts L-2-hydroxyglutarate to 2-ketoglutarate. Mutations inactivate it, causing acid accumulation.
Metabolic block: The enzyme deficiency creates a block in the Krebs cycle, disrupting cellular energy production and increasing oxidative stress in neurons.
Neurotoxicity: Elevated 2-hydroxyglutaric acid interferes with neurotransmitter synthesis and mitochondrial function, contributing to progressive brain damage.
D-2-Hydroxyglutaric aciduria: A related but distinct disorder caused by IDH2 mutations, leading to D-form accumulation and overlapping neurological symptoms.
Biomarker: Urinary 2-hydroxyglutaric acid levels exceed 100 mmol/mol creatinine in affected individuals, far above the normal range of less than 1 mmol/mol.
Enzyme activity: Patients show less than 5% residual L-2-HGDH activity in fibroblasts, confirming functional enzyme deficiency.

Comparison at a Glance

The following table compares key features of 2-hydroxyglutaric aciduria with related metabolic disorders:

Disorder	Gene Involved	Metabolite Accumulated	Inheritance	Typical Onset
2-Hydroxyglutaric aciduria	L2HGDH	L-2-hydroxyglutarate	Autosomal recessive	Infancy (0–2 years)
D-2-Hydroxyglutaric aciduria	IDH2	D-2-hydroxyglutarate	Autosomal dominant or recessive	Infancy to childhood
Glutaric aciduria type I	GCDH	Glutaric acid	Autosomal recessive	6–18 months
Propionic acidemia	PCCA or PCCB	Propionic acid	Autosomal recessive	Newborn period
Methylmalonic acidemia	MUT, MMACHC	Methylmalonic acid	Autosomal recessive	Neonatal to childhood

While all these disorders involve organic acid accumulation and neurological symptoms, 2-hydroxyglutaric aciduria is unique in its specific metabolite and gene mutation. Accurate differentiation is essential for prognosis and genetic counseling, as treatment strategies vary significantly.

Why It Matters

Recognizing 2-hydroxyglutaric aciduria is vital for early intervention and family planning. Though no cure exists, identifying the disorder early can improve quality of life through symptom management and monitoring.

Neurological impact: Affected children often experience developmental regression, epilepsy, and hypotonia, requiring lifelong multidisciplinary care.
Diagnostic challenge: Its rarity means it's often misdiagnosed as cerebral palsy or other neurodevelopmental disorders, delaying proper metabolic evaluation.
Genetic testing: Sequencing of L2HGDH allows definitive diagnosis and enables prenatal testing for at-risk families.
Treatment options: Currently limited to supportive care, including anticonvulsants, physical therapy, and dietary modifications to reduce metabolic stress.
Research significance: Studying this disorder contributes to understanding mitochondrial metabolism and neurodegenerative disease mechanisms.
Public health: Newborn screening programs do not routinely test for this condition, highlighting the need for expanded metabolic panels in high-risk populations.

As genomic medicine advances, improved detection and potential gene-based therapies may offer hope for future patients with this rare but severe disorder.